These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3214124)

  • 21. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacologic effects of caffeine and theophylline in the premature infant].
    Aranda JV; Clozel M
    Dev Pharmacol Ther; 1982; 4 Suppl():165-72. PubMed ID: 7128386
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of caffeine citrate and aminophylline for treating primary apnea in premature infants].
    Xu JL; Wang RQ; Chen DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1129-32. PubMed ID: 25406558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of caffeine compared with theophylline in the treatment of idiopathic apnea in premature infants.
    Fuglsang G; Nielsen K; Kjaer Nielsen L; Sennels F; Jakobsen P; Thelle T
    Acta Paediatr Scand; 1989 Sep; 78(5):786-8. PubMed ID: 2688355
    [No Abstract]   [Full Text] [Related]  

  • 25. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
    Larsen PB; Brendstrup L; Skov L; Flachs H
    Acta Paediatr; 1995 Apr; 84(4):360-4. PubMed ID: 7795341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.
    Jones RA; Baillie E
    Arch Dis Child; 1979 Mar; 54(3):190-3. PubMed ID: 434904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants.
    Khanna NN; Bada HS; Somani SM
    J Pediatr; 1980 Mar; 96(3 Pt 1):494-9. PubMed ID: 7359248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of theophylline on apnoea and hypoxaemic episodes in the premature neonate during the 1st 3 days after birth.
    du Preez MJ; Botha JH; McFadyen ML; Adhikari M
    Ann Trop Paediatr; 1998 Sep; 18(3):217-24. PubMed ID: 9924559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific Premature Groups Have Better Benefits When Treating Apnea With Caffeine Than Aminophylline/Theophylline.
    Lin YC; Tan YL; Yen TA; Chen CY; Tsao PN; Chou HC
    Front Pediatr; 2022; 10():817624. PubMed ID: 35281246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of theophylline to caffeine in premature newborn infants.
    Bory C; Baltassat P; Porthault M; Bethenod M; Frederich A; Aranda JV
    J Pediatr; 1979 Jun; 94(6):988-93. PubMed ID: 448554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of monitoring theophylline and caffeine plasma levels in the management of neonatal apnea].
    Soto Alvarez J; Sacristán del Castillo JA
    An Esp Pediatr; 1991 Apr; 34(4):310-2. PubMed ID: 2069282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rectal aminophylline in the management of apnoea of prematurity.
    Lyon AJ; McIntosh N
    Arch Dis Child; 1985 Jan; 60(1):38-41. PubMed ID: 3970566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of theophylline to caffeine in premature infants.
    Boutroy MJ; Vert P; Monin P; Royer RJ; Royer-Morrot MJ
    Lancet; 1979 Apr; 1(8120):830. PubMed ID: 86080
    [No Abstract]   [Full Text] [Related]  

  • 35. Transcutaneous oxygen monitoring in aminophylline-treated apneic infants.
    Peabody JL; Neese AL; Philip AG; Lucey JF; Soyka LF
    Pediatrics; 1978 Nov; 62(5):698-701. PubMed ID: 724312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The xanthine treatment of apnea of prematurity.
    Lucey JF
    Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
    [No Abstract]   [Full Text] [Related]  

  • 38. Theophylline or caffeine: which is best for apnea of prematurity?
    Gannon BA
    Neonatal Netw; 2000 Dec; 19(8):33-6. PubMed ID: 11949272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative Study of the Efficacy and Safety of Caffeine and Aminophylline for the Treatment of Apnea in Preterm Infants].
    Nagasato A; Nakamura M; Kamimura H
    Yakugaku Zasshi; 2018; 138(2):237-242. PubMed ID: 29386437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caffeine pharmacokinetics in preterm infants older than 2 weeks.
    Pearlman SA; Duran C; Wood MA; Maisels MJ; Berlin CM
    Dev Pharmacol Ther; 1989; 12(2):65-9. PubMed ID: 2714159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.